Doctor profile · Federal record
Dr. SARAH CREAMER, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · GRAND ISLAND, NE
- NPI 1659626927
- Accepts Medicare
- 15 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2620 W FAIDLEY AVE
GRAND ISLAND, NE 688034205
(308) 384-4600
Credentials & registration
- NPI registered
- July 2012 — 14 yrs on file
- Profile last updated
- April 14, 2020
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Nebraska #32283 · Texas #Q2794
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659626927. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
51,417
Distinct HCPCS
10
Medicare allowed
$879,559
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 16,500 | 16 | $1 | |
J1453 |
Injection, fosaprepitant, 1 mg | 13,650 | 29 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 10,207 | 14 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 3,780 | 14 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,966 | 49 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 940 | 29 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 842 | 326 | $117 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 680 | 25 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 647 | 249 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 277 | 63 | $118 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,773. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$2,969
Transactions
22
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 4 | $2,367.17 | |
| AIMMUNE THERAPEUTICS, INC. | 2 | $297.48 | |
| Octapharma USA, Inc. | 2 | $41.89 | |
| Novartis Pharmaceuticals Corporation | 2 | $39.30 | |
| ABBVIE INC. | 2 | $35.68 | |
| TerSera Therapeutics LLC | 1 | $33.03 | |
| Ipsen Biopharmaceuticals, Inc | 2 | $28.48 | |
| SERVIER PHARMACEUTICALS LLC | 1 | $22.95 | |
| Tempus AI, Inc | 1 | $21.86 | |
| Gilead Sciences, Inc. | 1 | $21.40 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $17.75 | |
| Astellas Pharma US Inc | 1 | $14.49 | |
| ARRAY BIOPHARMA INC | 1 | $14.03 | |
| Incyte Corporation | 1 | $13.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
663
Patients
170
Total drug cost
$54,072
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 228 | 48 | $3,796 |
| Gabapentin | Generic | 76 | 19 | $566 |
| Potassium Chloride | Generic | 56 | 15 | $1,348 |
| Tamoxifen Citrate | Generic | 41 | 13 | $1,003 |
| Letrozole | Generic | 39 | 12 | $1,506 |
| Prochlorperazine Maleate | Generic | 36 | 24 | $539 |
| Acyclovir | Generic | 31 | 0 | $454 |
| Eliquis (Apixaban) | Brand | 31 | 0 | $32,075 |
| Ondansetron Hcl | Generic | 31 | 21 | $797 |
| Dexamethasone | Generic | 21 | 18 | $633 |